Travere Therapeutics, Inc. Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

TVTX

Classifica tra le azioni #3574
Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies... Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II). Sparsentan received accelerated FDA approval in February 2023 and full approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) at risk of progression. In April 2026, the FDA approved FILSPARI to reduce proteinuria in adult and pediatric patients aged 8 and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome, making it the first and only FDA-approved medicine for FSGS. The company also markets Thiola and Thiola EC (tiopronin tablets) for cystinuria, a rare genetic disorder causing recurring kidney stones. Its pipeline includes pegtibatinase, an investigational enzyme replacement therapy for classical homocystinuria (HCU). Formerly Retrophin, Inc. (renamed November 2020), Travere is headquartered in San Diego, California, and incorporated in Delaware.
Prezzo delle azioni
$51.06
Capitalizzazione di mercato
$4.81B
Variazione (1 giorno)
1.13%
Variazione (1 anno)
83.08%
Paese
US
Scambia Travere Therapeutics, Inc. (TVTX)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Travere Therapeutics, Inc. (TVTX)
L’azione Travere Therapeutics, Inc. (simbolo: TVTX) ha subito un totale di 2 frazionamenti.
L’ultimo frazionamento è avvenuto il Nov 02, 2012.
Una quota di TVTX acquistata prima di Jul 02, 2009 equivale oggi a 0.0011111111111111 quote di TVTX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2012-11-02 1:9 x0.11111111111111 x0.0011111111111111
2009-07-02 1:100 x0.01 x0.01
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL